Dr. Rosenberg on Immunotherapy in Non-Metastatic Muscle Invasive Bladder Cancer

Jonathan E. Rosenberg, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, discusses immunotherapy in non-metastatic muscle-invasive bladder cancer.

Immunotherapy for this patient population is in an experimental stage, says Rosenberg.

Ongoing phase III trials are focusing on adjuvant therapy, which Rosenberg says patients who cannot receive platinum-based therapy after surgery should consider.